Soaring Eagle Acquisition Corp.

Soaring Eagle Acquisition Corp.

SRNG
Soaring Eagle Acquisition Corp.US flagNASDAQ Global Select
11.42
USD
+1.29
- -
Soaring Eagle Acquisition Corp.
SRNG
(NASDAQ Global Select)

Recent

price

11.42

P/E

ratio

- -

div

yld

- -

ROIC.AI

No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available
Business
Soaring Eagle Acquisition Corp. Soaring Eagle Acquisition Corp. (SRNG) is a blank check company sponsored by Eagle Equity Partners III, LLC that focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses, primarily targeting opportunities in growing industries with revenue growth potential and free cash flow generation; it offers no current products or services beyond its special purpose acquisition vehicle structure. Founded in 2020 and headquartered in New York, New York, the company, formerly known as Spinning Eagle Acquisition Corp., changed its name in February 2021 and completed its initial public offering in March 2021, raising proceeds for deployment in a target business combination. As of late 2025, Soaring Eagle Acquisition Corp. remains active as a SPAC without a completed de-SPAC merger since its prior combination with Ginkgo Bioworks Holdings, Inc. Ginkgo Bioworks Holdings, Inc. in September 2021, with its units (SRNGU) and shares trading on Nasdaq amid ongoing market activity and no announced recent partnerships, acquisitions, funding rounds, or strategic shifts within the last 1-2 years.

Company News

APIChat
  • Ginkgo Investigation Alert: Kessler Topaz Meltzer & Check, LLP is Investigating Securities Fraud Claims on Behalf of Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) Investors

  • DNA Stock Cooks Up 10% Gains on Ginkgo Biowork's First Trading Day

  • Ginkgo Bioworks to Begin Trading Today as NYSE: DNA with Over $1.6 Billion in Proceeds

  • Dear SRNG Stock Fans, Mark Your Calendars for Ginkgo Bioworks' Debut on Sept. 17

  • All Aboard For The BioRevolution

  • Is Ginkgo Bioworks Worth the Hype?

  • 3 Life Science Stocks Cathy Wood's Buying Hand Over Fist Right Now

  • Soaring Eagle Announces Extraordinary General Meeting Date for Proposed Business Combination with Ginkgo

  • Cathie Wood's Ark Invest just doubled a multi-million-share position in a SPAC merging with Ginkgo Bioworks

  • Soaring Eagle: SPAC Merger With Promising Synthetic Biology Specialist, Ginkgo Bioworks

  • 7 Jumbo IPOs to Put on Your Must-Buy Stocks List for 2021

  • Ginkgo Bioworks Announces Investor Day and Participation in Upcoming Investor Conferences

  • 'SPACs Attack' Recap: Looking Back At 3 SPAC Deals, SPAC Rumors And The Latest SPAC Headlines And Earnings

  • Ginkgo Bioworks Goes International Days After SPAC Announcement

  • 'SPACs Attack' Recap: Looking Back At 8 SPAC Deals Plus Latest SPAC Headlines And Earnings

  • Soaring Eagle: Meeting Ginkgo, One Of The Most Exciting SPAC Deals Yet

  • Ginkgo's $17.5 Bln SPAC Deal Presupposes Success

  • What Investors Should Know About Ginkgo Bioworks SPAC Deal: 'Cell Programming Has The Potential To Impact Every Physical Goods Industry'

  • Ginkgo Bioworks to go public in a $15B SPAC deal